Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
about
A New Scientific Paradigm may be Needed to Finally Develop an HIV VaccineNew concepts in HIV-1 vaccine developmentEnvelope variants circulating as initial neutralization breadth developed in two HIV-infected subjects stimulate multiclade neutralizing antibodies in rabbits.Stable, uncleaved HIV-1 envelope glycoprotein gp140 forms a tightly folded trimer with a native-like structure.Quantification of the epitope diversity of HIV-1-specific binding antibodies by peptide microarrays for global HIV-1 vaccine developmentA multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene.HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in MiceSequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C.New developments in an old strategy: heterologous vector primes and envelope protein boosts in HIV vaccine design.A recombinant multi-epitope protein MEP1 elicits efficient long-term immune responses against HIV-1 infection.Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers.Exploiting glycan topography for computational design of Env glycoprotein antigenicity.Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro.
P2860
Q26830360-637B28B6-0DC1-4850-B478-93309590178EQ28067027-D509B5CB-23DD-4744-A411-405D3E8805DBQ34594513-E041E202-D3FD-49F5-B980-578C39999833Q34831341-B9DF0DD2-EE4A-45CC-A88F-7219217DE109Q35072515-7F69144A-5CA6-4523-A870-86DAFEF22860Q35076748-45F76326-110A-4E4E-8422-DD00918DBD9FQ35110976-FB5EAE03-DEB4-476F-8359-F860E603EC3EQ36079913-287AC87C-106D-4A8D-8A09-80405F3CED50Q36132706-F8927FB8-E73D-4F90-BFC8-07985D8A354EQ38748193-F2F17600-3E8D-42C6-8E9D-21B03CEC1F8BQ40298230-B4E706EF-012D-462B-8B6F-80AB9432D20BQ41447893-EB694C88-908E-4CE9-B015-63194C5643F7Q52314288-2C7AFF32-A4BD-4212-8994-07BA1F87274FQ53693698-CDE4AFD6-E969-48DD-BF40-F09991115177Q55374996-C94B5202-7A71-4DA0-932D-7B51DA7D55A4
P2860
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
@ast
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
@en
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
@nl
type
label
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
@ast
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
@en
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
@nl
prefLabel
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
@ast
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
@en
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
@nl
P2093
P2860
P356
P1433
P1476
Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer
@en
P2093
Adrian Apetri
Ann Cheung
Christine A Bricault
Elena Giorgi
Els C M Brinkman-van der Linden
James M Kovacs
James Perry
Jennifer Shields
Joseph P Nkolola
P2860
P304
P356
10.1128/JVI.01739-14
P407
P577
2014-06-25T00:00:00Z